Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression.

RCMI Coordinating Center (RCMI CC)

Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression.

Piletz JE, Halaris A, Ernsberger PR. Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression. Crit Rev Neurobiol. 1994; 9(1):29-66.

View in: PubMed

subject areas

Animals
Depressive Disorder
Humans
Imidazoles
Monoamine Oxidase Inhibitors
Receptors, Adrenergic, alpha-2

authors with profiles

John Piletz

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support